Methods of improving myocardial performance in Fontan patients using udenafil compositions
US12048701B2 · kind B2 · utility
0Cited by
2References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 24, 2020 |
| Grant date | Jul 30, 2024 |
| Priority date | — |
| Expiry date | Nov 24, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to the field of using udenafil or a pharmaceutically acceptable salt thereof in patients who have undergone the Fontan operation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.